The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

The EACR’s Top 10 Cancer Research Publications: February 2022

October 17, 2025
EACR top 10 cancer research publications

The EACR’s Top 10 Cancer Research Publications is a regular summary of the most interesting and impactful recent papers in cancer research. It is curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

4. Dietary palmitic acid promotes a prometastatic memory via Schwann cells

  • 1. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
  • 2. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
  • 3. Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, BRAF-mutated Urothelial Carcinoma
  • 4. Dietary palmitic acid promotes a prometastatic memory via Schwann cells
  • 5. Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
  • 6. Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
  • 7. Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer
  • 8. Multi-omic machine learning predictor of breast cancer therapy response
  • 9. Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death
  • 10. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Previous
Next

Pascual, G., Domínguez, D., Elosúa-Bayes, M. et al. Nature 599, 485–490 (2021).

Summary of the findings

Fatty acid uptake and an altered metabolism are hallmarks of metastasis. In this work, we describe how dietary palmitic acid (and not oleic or linoleic acids) induces a more aggressive profile in tumour cells and how this remains as a form of cellular “memory”. Tumours from mice fed a short-term diet rich in palm oil and tumour cells
briefly exposed to palmitic acid in vitro remained highly metastatic even after being
successively transplanted (without further exposure to high levels of this fatty acid).

The prometastatic profile is related to the capacity of the tumour cells to establish a neural network around the tumour. The palmitic acid-induced prometastatic memory, which is dependent on the fatty acid transporter CD36, the transcription factor EGR2 and the glial-cell-stimulating peptide galanin, promotes a pro-regenerative state of tumour-activated Schwann cells, which secrete a specialized extracellular matrix. Intratumoural Schwann cells and innervation are parameters that strongly correlate with metastasis.

Using a variety of approaches to block the formation of the neural network surrounding the tumour, we were able to prevent the development of metastases.

Future impact of the findings

Our findings provide a novel insight into the metastasis initiation process and may drive new approaches to tackle cancer. In this regard, the mechanisms detailed in our work pave the way for the development of therapies that specifically block metastasis, which is the main cause of death by cancer.

Read more in Nature

4. Dietary palmitic acid promotes a prometastatic memory via Schwann cells

  • 1. Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
  • 2. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
  • 3. Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, BRAF-mutated Urothelial Carcinoma
  • 4. Dietary palmitic acid promotes a prometastatic memory via Schwann cells
  • 5. Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
  • 6. Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
  • 7. Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer
  • 8. Multi-omic machine learning predictor of breast cancer therapy response
  • 9. Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death
  • 10. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Previous
Next
Tags: EACR Top Ten Cancer Research Publications

Related Posts

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

January 16, 2026

Our guest in this episode is Bernhard Küster, Professor at the Technical University of Munich, Director of the Bavarian Biomolecular Mass Spectrometry Center and Co-Director of...

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

December 10, 2025

René Bernards (EACR Past President) and Johanna Joyce (EACR President Elect), together with Michael Baumann and Anton Berns, have written a new commentary highlighting the urgent...

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: December 2025

December 8, 2025

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

Colin Ratcliffe two years into his EACR-AstraZeneca Postdoctoral Fellowship
News

Colin Ratcliffe’s experience of an EACR-AstraZeneca Postdoctoral Fellowship

February 6, 2026
Amel Aziba receives EACR-Molecular Oncology Editorial Fellowship
News

Amel Aziba receives EACR-Molecular Oncology Editorial Fellowship

February 2, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR